Hims and Hers Health is planning to cash in on Novo Nordisk losing its semaglutide drug exclusivity in Canada. The telehealth ...

One in eight Americans use GLP-1 weight-loss drugs, but are they getting the real thing? Novo Nordisk's dramatic exit from a popular platform reveals the hidden risks of online prescriptions.

Stocks that pay dividends tend to outperform ones that don't. Consensus price targets for Novo Nordisk suggest the stock can ...

LLY has slid 15.7% over the past year, but surging demand for Mounjaro and Zepbound could revive the stock's momentum.

The number of reported measles cases in the United States has hit 1,288 in the first six months of this year, the most since ...

Biocon Ltd. plans to file for regulatory approvals of generic versions of Novo Nordisk A/S’s Ozempic and Wegovy in key ...

Biocon share price gained 2.5 per cent after reports suggested that the company is planning to file for generic versions of ...

The Bengaluru-based company is seeking approval of generic Ozempic by September from Canadian authorities, and also in some ...

Detailed price information for Starbucks Corp (SBUX-Q) from The Globe and Mail including charting and trades.

A new sport-utility vehicle launched by Xiaomi has drawn a rush of first-day orders. The sneaker and athletic apparel company expects the decline in its sales and margins to slow in the current ...

Detailed price information for Tandem Diabetes Care (TNDM-Q) from The Globe and Mail including charting and trades.